Exubera
NantWorks to invest $85.5m in former Pfizer plant
January 16, 2012Manufacturing and Production Exubera, Nantworks, Pfizer
A former Pfizer manufacturing facility in Indiana, US, looks set for a new lease of life after technology company NantWorks …
Pfizer abandons Exubera
October 19, 2007Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …
Exubera approval limited to needle-phobic patients
January 26, 2007Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin
Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …
Pfizer to go it alone with Exubera
January 16, 2006Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
October 4, 2026
Migraine annual economic and quality-of-life burden in UK
October 1, 2026
bit.bio expands human heart cell portfolio through myriamed partnership
September 30, 2026
